Physician profile
Benjamin Daniel Bush
NPI 1235484429
$1,876.31
in general payments reported to CMS, 2019-2025
11 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $781 · 2020: $14.02 · 2021: $112 · 2022: $35.89 · 2023: $275 · 2024: $455 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610 · Travel and Lodging: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.08 |
| Travel and Lodging | $323.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,553.98 | 2019-2025 | Inspire |
| Stryker Corporation | $89.07 | 2021-2024 | Nasopore, Clarifix Cryotherapy Device, Audion Et Dilation System |
| Regeneron Healthcare Solutions, INC. | $47.80 | 2023-2024 | Dupixent |
| Optinose US, INC. | $37.48 | 2021-2024 | |
| Medtronic, INC. | $36.50 | 2021-2022 | |
| Genzyme Corporation | $27.67 | 2025 | |
| Intersect Ent, INC. | $25.88 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $16.54 | 2023 | |
| Aerin Medical INC. | $16.47 | 2023 | |
| Glaxosmithkline, LLC. | $13.53 | 2021 | |
| Acclarent, INC | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Bush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.